Core Viewpoint - The article highlights the rise of fraudulent practices in the youth height enhancement industry, where companies make exaggerated claims about their ability to increase children's height, leading to consumer complaints and potential scams [2][10][14]. Group 1: Company Practices - Various businesses, such as "Anlishen" and "Dejiri," promote height enhancement services, claiming to provide "accelerators" for children's growth, which appeals to parents' hopes [2][4]. - "Anlishen" and "Dejiri" both use "contract guarantee, ineffective refund" as a core promise to attract parents, despite the questionable efficacy of their services [6][10]. - The headquarters of "Anlishen" admits that children will grow regardless of their services, indicating a lack of transparency in their marketing [10][14]. Group 2: Consumer Complaints - Consumers have reported being deceived by these companies, leading to complaints during the "3.15" consumer rights event [2]. - After media exposure, many promotional contents related to these companies were removed from various online platforms, indicating a response to public outcry [14]. Group 3: Company Backgrounds - "Anlishen Health Management Co., Ltd." was established in April 2024 with a registered capital of 1 million RMB, focusing on health consulting and management services [15]. - "Dejiri Health Management Co., Ltd." was founded in June 2018 with a registered capital of 100,000 RMB, and has faced legal issues related to unauthorized use of celebrity images in their marketing [19]. - "Suzhou Yingruike Health Management Co., Ltd." was established in September 2024 with a registered capital of 500,000 RMB, also focusing on health consulting services [18]. Group 4: Industry Overview - As of now, there are over 17.195 million healthcare-related enterprises in China, with Guangdong, Shandong, and Henan leading in the number of such companies [20]. - Among healthcare-related businesses, 1.37% have faced legal lawsuits, 3.57% have experienced operational anomalies, and 1.13% have been subject to administrative penalties [20].

Core Viewpoint - The article highlights the prevalence of fraudulent height-increasing services targeting children, with multiple companies making misleading claims about their effectiveness and safety [1][7][10]. Group 1: Company Practices - Various businesses, such as "安立身青少年物理增高" and "德脊瑞青少年物理增高," are promoting height-increasing treatments with promises of refunds if results are not achieved [3][7]. - The "安立身" company claims that children will grow regardless of their services, but does not disclose this to parents [5][10]. - "德脊瑞" claims to have unique technology for height increase, but the equipment's actual function is unrelated to height growth, focusing instead on inflammation and pain relief [9][10]. Group 2: Misleading Claims - The "德脊瑞" company has been found to misrepresent its patents, which do not support claims of stimulating bone growth [9][10]. - Another company, "英瑞可," makes scientifically unfounded claims about increasing height in individuals with closed growth plates, stating they can provide various treatments without any medical validation [10][12]. Group 3: Company Backgrounds - "安立身健康管理有限公司" was established in April 2024 with a registered capital of 1 million RMB, focusing on health consulting and management services [12][13]. - "苏州英瑞可健康管理有限公司" was founded in September 2024 with a registered capital of 500,000 RMB, also offering health consulting and management services [15][17]. Group 4: Industry Overview - As of now, there are over 17.19 million healthcare-related enterprises in China, with Guangdong, Shandong, and Henan leading in numbers [19]. - Among healthcare businesses, 1.37% have faced legal disputes, 3.57% have experienced operational anomalies, and 1.13% have been subject to administrative penalties [19].